- November 25, 2024 - First Case of Clade I Mpox Diagnosed in the United States
- November 7, 2024 - First Marburg Virus Disease Outbreak in the Republic of Rwanda (Update)
- November 7, 2024 - Human-to-Human Transmission of Clade I Mpox in the Democratic Republic of Congo with Spread to Neighboring Countries (Update)
- October 16, 2024 - Travel Advisory: Marburg Virus Disease in Rwanda
- October 9, 2024 - Acute Flaccid Myelitis Recommendations and Reporting
- October 8, 2024 - Travel Advisory: Oropouche Virus in the Americas
- October 8, 2024 - Increased Oropouche Virus Activity and Associated Risk to Travelers
- October 8, 2024 - Medetomidine, a potent sedative, found in the District of Columbia’s Drug Supply
- October 7, 2024 - First Marburg Virus Disease Outbreak in the Republic of Rwanda
- September 27, 2024 - Increase in Pertussis Cases in the District of Columbia
- August 22, 2024 - Travel Advisory: Clade I Mpox in the Democratic Republic of Congo with Spread to Neighboring Countries
- August 22, 2024 - Human-to-Human Transmission of Clade I Mpox in the Democratic Republic of Congo with Spread to Neighboring Countries
- August 14, 2024 - Increased Global Risk of Dengue Fever (Update)
- June 28, 2024 - Highly Pathogenic Avian Influenza A(H5N1) Virus: Identification of Human Infection and Recommendations for Investigations and Response (Update)
- June 18, 2024 - Increased Global Risk of Dengue Fever
- June 7, 2024 - Meningococcal Disease Cases Linked to Travel to the Kingdom of Saudia Arabia (KSA): Ensure Pilgrims are Current on Meningococcal Vaccination
- May 7, 2024 - Highly Pathogenic Avian Influenza A(H5N1) Virus: Identification of Human Infection and Recommendations for Investigations and Response
- May 2, 2024 - Increase in Invasive Serogroup Y Meningococcal Disease in the United States
- March 12, 2024 - Respiratory Disease Isolation Guidance
- January 10, 2024 - Gonorrhea Outbreak Health Advisory Notice
